Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Camras

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Ophthalmology|January 1, 1996
Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study GroupC B Camras
Ophthalmology|November 18, 1998
CME and anterior uveitis with latanoprost useC B Camras
American Journal of Ophthalmology|February 22, 2000
Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit; latanoprost and herpes simplex keratitisC B Camras
Investigative Ophthalmology & Visual Science|May 1, 2001
Introducing Laszlo Bito and Johan Stjernschantz, the 2000 recipients of the Proctor MedalC B Camras
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Mechanism of the prostaglandin-induced reduction of intraocular pressure in humansC B Camras
Journal of Glaucoma|November 19, 2009
Clinical Applications of alpha2-Adrenergic Agonists in OphthalmologyC B Camras
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 25, 1999
Latanoprost may trigger the biosynthesis of endogenous prostaglandins in early postoperative pseudophakiasC B Camras
American Journal of Ophthalmology|February 1, 2000
Does that drug work? Pitfalls in studies on the efficacy and safety of glaucoma medicationsC B Camras, D Minckler
Survey of Ophthalmology|February 1, 1997
Initial clinical studies with prostaglandins and their analoguesC B Camras, A Alm
Current Eye Research|January 1, 1981
Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alphaC B Camras, L Z Bito
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Ophthalmology|January 1, 1996
Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study GroupC B Camras
Ophthalmology|November 18, 1998
CME and anterior uveitis with latanoprost useC B Camras
American Journal of Ophthalmology|February 22, 2000
Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit; latanoprost and herpes simplex keratitisC B Camras
Investigative Ophthalmology & Visual Science|May 1, 2001
Introducing Laszlo Bito and Johan Stjernschantz, the 2000 recipients of the Proctor MedalC B Camras
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Mechanism of the prostaglandin-induced reduction of intraocular pressure in humansC B Camras
Journal of Glaucoma|November 19, 2009
Clinical Applications of alpha2-Adrenergic Agonists in OphthalmologyC B Camras
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 25, 1999
Latanoprost may trigger the biosynthesis of endogenous prostaglandins in early postoperative pseudophakiasC B Camras
American Journal of Ophthalmology|February 1, 2000
Does that drug work? Pitfalls in studies on the efficacy and safety of glaucoma medicationsC B Camras, D Minckler
Survey of Ophthalmology|February 1, 1997
Initial clinical studies with prostaglandins and their analoguesC B Camras, A Alm
Current Eye Research|January 1, 1981
Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alphaC B Camras, L Z Bito
Pageof 6